PlainPharmaWatch

CMS Open Payments · Program Year 2024

BlueRock Therapeutics LP

BlueRock Therapeutics LP reported $405,904.40 in payments to 4 physicians and teaching hospitals across 4 transactions.

See the rankings → How this is sourced
$405.9K
Total payments
4
Transactions
4
Recipients
+$281.2K
General Payments vs PY2023

BlueRock Therapeutics LP reported $405,904.40 in payments to 4 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #815 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $101.5K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

BlueRock Therapeutics LP pairs above-median payment volume with a concentrated payment pattern focused on a handful of top recipients.

#815
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

BlueRock Therapeutics LP's CMS-reported General Payments increased by $281.2K (+225.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: BLUEROCK THERAPEUTICS LPPY2024: BlueRock Therapeutics LP. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$124.7KPY2024$405.9K
PY2023
$124,742.63
PY2024
$405,904.40

How BlueRock Therapeutics LP ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

BlueRock Therapeutics LP's total vs. every reporting company

CMS Open Payments, Program Year 2024

$405,904 Top 42% higher than 58% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for BlueRock Therapeutics LP

In Program Year 2024, BlueRock Therapeutics LP reported $405,904.40 in payments to 4 physicians and teaching hospitals across 4 individual transactions, an average of $101.5K per transaction and $101.5K per recipient. That total places BlueRock Therapeutics LP at rank #815 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 1 general-payment categories charted below, "Acquisitions" is the largest at $405.9K across 4 transactions, 100.0% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 1 types of general payments, BlueRock Therapeutics LP's largest category was "Acquisitions" at $405.9K - 100.0% of the company's reported total.

How BlueRock Therapeutics LP divides its payments

General-payment categories, ordered by reported total

1. Acquisitions$405.9K
Payment Type Amount Transactions
Acquisitions $405.9K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $405,904.40 (100.0%) of $405,904.40 in this company's General Payments records across 4 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for BlueRock Therapeutics LP

The five named recipients with the highest reported General Payments from this company

Bruce R Blazar$295.0KViviane S Tabar$57.5KBrendon P Boot$40.3KKwan-Hong Min$13.1K
  1. 1

    Bruce R Blazar

    $295,048.16 across 1 reported transactions

  2. 2

    Viviane S Tabar

    $57,460.08 across 1 reported transactions

  3. 3

    Brendon P Boot

    $40,262.31 across 1 reported transactions

  4. 4

    Kwan-Hong Min

    $13,133.85 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $101.5K. Average per recipient: $101.5K.

Total Amount

$405,904.40

Avg per Transaction

$101.5K

Avg per Recipient

$101.5K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

BlueRock Therapeutics LP Share

0.0%

#815 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to BlueRock Therapeutics LP

Ivoclar Vivadent, Inc.

$405.7K 1,041 recipients

Amarin Pharma Inc.

$405.1K 300 recipients

Nova Eye, Inc.

$404.7K 474 recipients

Mizuho America, Inc.

$403.0K 57 recipients

Onkos Surgical, Inc.

$402.3K 461 recipients

Geistlich Pharma, North America, Inc.

$401.7K 2,543 recipients

Frequently Asked Questions

How much did BlueRock Therapeutics LP pay to physicians and hospitals in 2024? ▾
BlueRock Therapeutics LP made $405,904.40 in payments to physicians and hospitals in Program Year 2024, across 4 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from BlueRock Therapeutics LP? ▾
BlueRock Therapeutics LP made payments to 4 physicians and teaching hospitals in 2024. The average payment per recipient was $101.5K.
What types of payments did BlueRock Therapeutics LP make? ▾
BlueRock Therapeutics LP made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Acquisitions" at $405.9K, representing 100.0% of the company's reported total.
How does BlueRock Therapeutics LP rank among pharmaceutical companies? ▾
By total payment amount, BlueRock Therapeutics LP sits at #815 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from BlueRock Therapeutics LP? ▾
The average transaction from BlueRock Therapeutics LP was $101.5K in 2024. The company made 4 total transactions to 4 recipients.
Where does the payment data for BlueRock Therapeutics LP come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download BlueRock Therapeutics LP's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.